CanCuRX

Pancreatic Cancer Treatment

Active Seed Startup Haifa Founded 2016-02

CanCuRX is a preclinical-stage biopharmaceutical company aiming to improve survival for patients with pancreatic cancer through the development of a novel treatment based on the properties of a mushroom-derived compound that arrests pancreatic cell growth. CanCuRX is working with the Carmel Innovations Fund of the University of Haifa. CanCuRX has patents re…

SectorHealth Tech & Life Sciences
StageSeed
Employees6
Founded2016-02
HQHaifa
Patents1
Confidence85
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technology
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals